Alexander Mauskop

Summary

Publications

  1. ncbi request reprint The use of botulinum toxin in the treatment of headaches
    Alexander Mauskop
    New York Headache Center, 30 East 76th Street, New York, NY 10021, USA
    Curr Pain Headache Rep 6:320-3. 2002
  2. ncbi request reprint Clinical features of withdrawal headache following overuse of triptans and other headache drugs
    Alexander Mauskop
    Neurology 58:1443; author reply 1443-4. 2002
  3. ncbi request reprint Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study
    David W Dodick
    Department of Neurology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Headache 45:315-24. 2005
  4. ncbi request reprint Botulinum toxin in headache treatment: the end of the road?
    Alexander Mauskop
    Cephalalgia 27:468. 2007

Detail Information

Publications4

  1. ncbi request reprint The use of botulinum toxin in the treatment of headaches
    Alexander Mauskop
    New York Headache Center, 30 East 76th Street, New York, NY 10021, USA
    Curr Pain Headache Rep 6:320-3. 2002
    ..This makes botulinum toxin a preferred treatment for many patients. The large controlled trials that are underway may lead to a wider acceptance of this treatment by neurologists and pain specialists...
  2. ncbi request reprint Clinical features of withdrawal headache following overuse of triptans and other headache drugs
    Alexander Mauskop
    Neurology 58:1443; author reply 1443-4. 2002
  3. ncbi request reprint Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study
    David W Dodick
    Department of Neurology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Headache 45:315-24. 2005
    ..Irvine, CA) for the prophylaxis of headaches in patients with chronic daily headache (CDH) without the confounding factor of concurrent prophylactic medications...
  4. ncbi request reprint Botulinum toxin in headache treatment: the end of the road?
    Alexander Mauskop
    Cephalalgia 27:468. 2007